If You Invested in Cbd Life Science (CBDL)
Looking for the live price? See the CBDL quote & overviewWhat $1,000 or $10,000 in CBDL Would Be Worth Today
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Jul 6, 2015 |
|---|---|---|---|---|
| $1,000 | $1,000 +0% | $2 -100% | $0 -100% | $0 -100% |
| $10,000 | $10,000 +0% | $20 -100% | $0 -100% | $0 -100% |
Based on real historical closing prices through the latest market close. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for CBDL$1,000 Investment Over Time
CBDL vs S&P 500Year-by-Year Returns
CBDL annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2017 | $26986.51 | $2998.50 | -88.9% | -88.9% |
| 2018 | $5997.00 | $36.00 | -99.4% | -99.9% |
| 2019 | $33.00 | $0.43 | -98.7% | -100.0% |
| 2020 | $0.47 | $0.48 | +3.2% | -100.0% |
| 2021 | $0.48 | $0.06 | -87.5% | -100.0% |
| 2022 | $0.09 | $0.00 | -99.7% | -100.0% |
| 2023 | $0.03 | $0.00 | -99.0% | -100.0% |
| 2024 | $0.00 | $0.00 | +66.7% | -100.0% |
| 2025 | $0.00 | $0.00 | -60.0% | -100.0% |
| 2026 | $0.00 | $0.00 | +50.0% | -100.0% |
About Cbd Life Science
Healthcare · OTC Link
CBD Life Sciences Inc. (CBDL) is a publicly traded health-and-wellness company focused on the development, manufacturing, marketing, and distribution of CBD-based and plant-based wellness products. Through its flagship brand The CBD Vault, the company offers premium cannabidiol (CBD), hemp, cannabis, functional mushroom, and nutraceutical formulations that target pain relief, relaxation, performance, and general wellness across multiple consumer categories.
CBD Life Sciences is described in its press materials as operating in the CBD and cannabis marketplace, with an emphasis on topicals, tinctures, edibles, beverages, functional supplements, and mushroom-based products. The company positions The CBD Vault as its main retail and wholesale platform, supplying products to dispensaries, luxury spas, wellness retailers, and online channels. CBDL trades on the OTC market under the symbol CBDL.
Business focus and product portfolio
According to multiple company announcements, CBD Life Sciences Inc. concentrates on CBD wellness products and related plant-based formulations. Its portfolio under The CBD Vault brand has included:
- Topicals and pain relief products, such as CBD Pain Relief Cream, CBD Massage Oil, Pain Relief Roll-On, and high-strength hemp-derived pain creams.
- Ingestible CBD products, including full spectrum gummies, CBD infused tea, tinctures, and other edibles.
- CBD beverages, such as CBD Lemonade, Raspberry Lemonade, Lavender Lemonade, CBD-Infused Water, and CBD seltzer, which the company highlights as part of a growing beverage division.
- Functional mushroom and mushroom-infused products, including Reishi Mushroom Face Cream, functional mushroom blends, and a mushroom-infused chocolate bar described as part of the Mushroom Madness product line.
- Plant-based nutraceuticals and hemp-free wellness products, such as energy and diet/weight-loss gummies formulated with vegan, plant-based ingredients.
- Pet and animal wellness formulations, referenced by the company as veterinarian-developed and equine-focused in its communications.
Across its communications, CBDL emphasizes premium formulations, performance-focused ingredients, and plant-based or hemp-derived actives. The company describes itself as expanding beyond CBD-only offerings into broader wellness and functional nutrition categories while maintaining CBD and hemp products as a core part of its identity.
Brand structure and distribution channels
CBD Life Sciences Inc. operates through its wholly owned subsidiary CBD Vault, which the company identifies as its primary retail and distribution arm. CBD Vault is presented as the consumer-facing brand for CBDL’s CBD, hemp, cannabis, mushroom, and wellness products. In various press releases, the company notes activity in:
- Wholesale distribution to licensed dispensaries, including partnerships and orders with Smoking Scholars in the Bronx, New York, and a Letter of Intent with a dispensary in New Jersey.
- Retail placements in luxury spa locations, such as Red Hots Spa at Garden City Hotel and in Roslyn, New York, and in high-traffic environments like Mother Earth Juice Bar at John F. Kennedy International Airport.
- E-commerce and marketplace channels, with references to approval for certain products on online marketplaces and plans for expanded catalog strategies.
- Direct retail operations under CBDL’s own branding, referenced in the context of cross-distribution agreements where partner products may be stocked in CBDL’s locations.
The company’s communications describe a strategy that combines dispensary partnerships, spa and hospitality placements, beverage distribution opportunities, and online sales to broaden its national footprint.
Key product categories highlighted by the company
CBD Life Sciences Inc. repeatedly emphasizes several product categories in its public statements:
- Pain relief and anti-inflammatory topicals: CBD Pain Relief Cream, Pain Relief Roll-On, hemp-derived pain creams with varying strengths, and a Tremendous Anti-Inflammatory Soothe Gel formulated for spa clientele.
- CBD ingestibles and edibles: full spectrum gummies, CBD infused tea, and other CBD-based consumables described as part of its wellness offerings.
- CBD beverages: lemonades, CBD-Infused Water, and CBD seltzers, which the company associates with dispensary sales and potential stadium distribution.
- Functional mushroom products: Reishi Mushroom Face Cream, functional mushroom blends, and a mushroom-infused chocolate bar marketed as combining wellness attributes with confectionery appeal.
- Hemp-free nutraceutical gummies: energy and diet/weight-loss gummies formulated with plant-based ingredients, positioned as part of a broader wellness and performance nutrition strategy.
These categories illustrate CBDL’s focus on both CBD-centric and adjacent wellness segments, including functional foods, beverages, and supplements.
Market positioning and sector context
In its news releases, CBD Life Sciences Inc. situates itself within the CBD, cannabis, functional beverage, and wellness supplement markets. The company references projections for growth in CBD, pain management, functional gummies, functional mushrooms, and cannabis dispensary sales, and presents its activities as aligned with those expanding sectors. CBDL’s communications describe its role as a participant in these markets through product development, manufacturing, and distribution under The CBD Vault brand.
The company also highlights participation in industry events such as the NECANN New Jersey Cannabis Conference, using those events to showcase its product suite and build relationships with dispensary operators and other potential partners.
Geographic and channel emphasis
CBD Life Sciences Inc. frequently references activity in New York and New Jersey through dispensary and spa partnerships, as well as broader plans for nationwide retail, wholesale, and online distribution. The company’s press materials identify Scottsdale, Arizona as the location cited in its news datelines. Its distribution strategy, as described by the company, includes East Coast dispensaries, luxury hospitality venues, airport retail, and potential sports stadium beverage placements, alongside e-commerce and marketplace channels.
Business model characteristics
Based on company statements, CBD Life Sciences Inc.’s business model centers on:
- Product development and formulation of CBD, hemp, cannabis, mushroom, and plant-based wellness products under The CBD Vault and related branding.
- Manufacturing and sourcing to support scalable production of topicals, beverages, edibles, and supplements.
- Wholesale and retail distribution through dispensaries, spas, hospitality venues, and other retailers, as well as online and marketplace channels.
- Brand-building via participation in trade conferences, media appearances, and partnerships with retailers and dispensaries.
The company’s communications emphasize expansion of its product catalog and distribution footprint as core elements of its growth approach.
Company status and regulatory filings
CBD Life Sciences Inc. is described in its releases as a publicly traded company on the OTC market under the symbol CBDL. The provided data notes that there are no SEC filings available for this company in the referenced source set. The news items do not state that CBDL has been delisted, acquired, or has ceased operations, and they present the company as active within the CBD and wellness sectors.
FAQs about CBD Life Sciences Inc. (CBDL)
Similar Stocks
See how related companies performed
Frequently Asked Questions
Cbd Life Science investment returns
How much would $1,000 invested in Cbd Life Science be worth today?
If you invested $1,000 in Cbd Life Science (CBDL) 10 years ago on 2016-07-05, your investment would be worth $0 today, representing a -100.0% total return, growing at a compounded rate of -83.7% per year (CAGR).
Has Cbd Life Science outperformed the S&P 500?
Over the past 10 years, CBDL returned -100.0% compared to +257.4% for the S&P 500, underperforming the benchmark by 357.4 percentage points.
What is Cbd Life Science's average annual return?
The compound annual growth rate (CAGR) of CBDL over the past 10 years is -83.7%, growing at a compounded rate each year. Individual years vary significantly — CBDL's best recent year was 2024 (+66.7%) and worst was 2022 (-99.7%).
Your Privacy is Protected
This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.
For informational and educational purposes only — not investment advice.
